Galantamine (Cadila Healthcare Limited)
Welcome to the PulseAid listing for the Galantamine drug offered from Cadila Healthcare Limited. This Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cadila Healthcare Limited |
NON-PROPRIETARY NAME: | Galantamine |
SUBSTANCE NAME: | GALANTAMINE HYDROBROMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2011-10-10 |
END MARKETING DATE: | 0000-00-00 |
Galantamine HUMAN PRESCRIPTION DRUG Details:
Item Description | Galantamine from Cadila Healthcare Limited |
LABELER NAME: | Cadila Healthcare Limited |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 4(mg/1) |
START MARKETING DATE: | 2011-10-10 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 65841-755_ffd1924e-985e-417d-a7bc-7be5e5168b31 |
PRODUCT NDC: | 65841-755 |
APPLICATION NUMBER: | ANDA078898 |
Other GALANTAMINE HYDROBROMIDE Pharmaceutical Manufacturers / Labelers: